Crinetics Pharmaceuticals to Participate in The 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire December 18, 2025 SAN DIEGO, Dec. 18, 2025 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that that Scott Struthers, Ph.D., Founder and Chief Executive Officer of Crinetics, will present at the 44th Annual J.P. Morgan Healthcare Conference being held […]

Parsons Names John Martinez as the Company's Next Chief Legal Officer GlobeNewswire December 18, 2025 CHANTILLY, Va., Dec. 18, 2025 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE:PSN) has named proven executive and legal expert John Martinez as the company's next chief legal officer (CLO), effective February 16, 2026. The announcement follows the notification by current CLO

vTv Therapeutics and M42's IROS Announce Submission of Phase 2 Clinical Study Protocol for Cadisegliatin in Type 2 Diabetes to the United Arab Emirates Department of Health Trial to assess cadisegliatin as potential adjunctive therapy to insulin in patients with T2D GlobeNewswire December 18, 2025 HIGH POINT, N.C., Dec. 18, 2025 (GLOBE NEWSWIRE) — vTv

Abivax to be Added to Nasdaq Biotechnology Index GlobeNewswire December 18, 2025 Abivax to be Added to Nasdaq Biotechnology Index PARIS, France – December 18, 2025 – 10:05 pm CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing therapeutics that harness

NANO Nuclear Reports Fiscal Year 2025 Financial Results and Provides Business Update GlobeNewswire December 18, 2025 Management to hold webcast today at 5:00 pm Eastern New York, N.Y., Dec. 18, 2025 (GLOBE NEWSWIRE) — NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear micro modular reactor and technology company

Safe Harbor Financial Statement on Federal Cannabis Rescheduling and the Resulting Growth Opportunity for Its Banking Platform Improved operator economics and expanding institutional interest position Safe Harbor for scalable, compliant growth GlobeNewswire December 18, 2025 DENVER, Dec. 18, 2025 (GLOBE NEWSWIRE) — SHF Holdings, Inc., d/b/a Safe Harbor Financial (NASDAQ: SHFS) (“Safe Harbor” or the

Cartesian Therapeutics Announces the Appointment of Adrian Bot to Board of Directors GlobeNewswire December 18, 2025 FREDERICK, Md., Dec. 18, 2025 (GLOBE NEWSWIRE) — Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced the appointment of Adrian Bot, M.D., Ph.D., to the Company's Board of

HF Foods Group Opens State-of-the-Art Distribution Warehouse in Powder Springs, GA Opens an advanced 190,000 square foot distribution center driven by increased market demand GlobeNewswire December 18, 2025 POWDER SPRINGS, Ga., Dec. 18, 2025 (GLOBE NEWSWIRE) — HF Foods Group (Nasdaq: HFFG) (“HF Foods” or the “Company”), a leading distributor of international foodservice solutions to

Toronto, Ontario–(Newsfile Corp. – December 18, 2025) – Mines D’Or Orbec Inc. (TSXV: BLUE) (OTC Pink: BLTMF) (“Orbec” or the “Company“) is pleased to announce that the Ontario Superior Court of Justice (Commercial List) issued a final order approving the previously announced plan of arrangement under the Business Corporations Act (Ontario) (the “Arrangement“) pursuant to

(NASDAQ:CUE), BOSTON, Dec. 18, 2025 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of autoimmune disease, today announced that it is commencing an underwritten public offering of shares of its common stock (or